BYG4lab
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
BYG4lab - overview
Established
1982
Location
-, -, France
Primary Industry
Software
About
Based in France, and founded in 1982, Byg Informatique – SAS doing business as BYG4lab, operates as a software company that provides middleware data management solutions for the healthcare industry. In July 2022, Keensight Capital, along with the company's management, acquired a majority stake in Byg Informatique – SAS. As of August 2022, the company has a team of 80 people led by its CEO Cyril Verhille. Byg Informatique – SAS offers transversal middleware, microbiology middleware, point of care middleware, epidemiology hygiene, immuno- hematologie, quality expertise, business intelligence, and master data management.
The company also offers various services such as workflow management, project management, proactive online services, training courses, designing personalized dashboards, maximizing automatic validation, and managing quality control.
Current Investors
Keensight Capital
Primary Industry
Software
Sub Industries
IT Security/Cybersecurity, Systems Management Software, Medical Software
Website
http://www.byg4lab.com
Verticals
HealthTech
Company Stage
Mature - Buyout
Total Amount Raised
Subscriber access only
BYG4lab - timeline of key events
BYG4lab - financials
| Fiscal Year Ended | Dec 31, 2016 | Dec 31, 2017 | Dec 31, 2018 | Dec 31, 2019 | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue (USD) | 4,980,351 | 5,344,313 | 5,907,573 | 7,309,840 | 7,775,636 | 9,593,018 | - | - | - |
| % Revenue Growth (YoY) | - | 7.3% | 10.5% | 23.7% | 6.4% | 23.4% | - | - | - |
| EBITDA (USD) | 1,376,977 | 1,657,621 | 1,642,905 | 2,346,609 | 2,796,915 | 2,810,108 | - | - | - |
| Operating Income (USD) | 1,296,371 | 1,541,319 | 1,497,663 | 2,163,606 | 2,600,799 | 2,352,183 | - | - | - |
| Operating Margin | 26.0% | 28.8% | 25.4% | 29.6% | 33.4% | 24.5% | - | - | - |
| % EBITDA Margin | 27.6% | 31.0% | 27.8% | 32.1% | 36.0% | 29.3% | - | - | - |
| NET Income (USD) | 807,598 | 974,128 | 1,240,119 | 1,204,860 | 1,894,772 | 2,213,627 | - | - | - |
| % Net Margin | 16.2% | 18.2% | 21.0% | 16.5% | 24.4% | 23.1% | - | - | - |
BYG4lab - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Add-on | Completed | Finbiosoft Oy | - | ||||||||
| Buyout | Completed | BYG4lab | - |
Displaying 1 - 2 of 2
BYG4lab - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.